Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias

Leuk Lymphoma. 2024 Jun 2:1-4. doi: 10.1080/10428194.2024.2350670. Online ahead of print.

¹ Department of Pharmacy, University of Utah Hospitals and Clinics, Huntsman Cancer Institute, UT, USA.
² Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA.

No abstract available